Samantha Weber, Natascha Stoffel, Juan Ansede-Bermejo, Raquel Cruz, Álvaro Del Real Bolt, Rupert Bruckmaier, Ángel Carracedo, Selma Aybek
{"title":"Salivary oxytocin and amygdalar alterations in functional neurological disorders.","authors":"Samantha Weber, Natascha Stoffel, Juan Ansede-Bermejo, Raquel Cruz, Álvaro Del Real Bolt, Rupert Bruckmaier, Ángel Carracedo, Selma Aybek","doi":"10.1093/braincomms/fcae455","DOIUrl":null,"url":null,"abstract":"<p><p>Individuals diagnosed with functional neurological disorder experience abnormal movement, gait, sensory processing or functional seizures, for which research into the pathophysiology identified psychosocial contributing factors as well as promising biomarkers. Recent pilot studies suggested that (epi-)genetic variants may act as vulnerability factors, for example, on the oxytocin pathway. This study set out to explore endogenous oxytocin hormone levels in saliva in a cohort of 59 functional neurological disorder patients and 65 healthy controls comparable in sex and age. First, we examined the association between salivary oxytocin levels with the genetic allelic variant (rs53576) of the oxytocin receptor gene (<i>OXTR</i>), its epigenetic changes indicated by methylation rates, and clinical variables-including childhood trauma. Second, due to previously reported effects of oxytocin changing the volume and functional connectivity of the amygdala, as well as the known involvement of the amygdala in the pathophysiology of functional neurological disorders, we further looked at both structural and functional imaging of the amygdala. While patients did not significantly differ from healthy control in their peripheral oxytocin levels, there was a specific interaction of <i>OXTR</i> methylation and peripheral oxytocin dependent on group: higher methylation rates correlated with higher salivary oxytocin in patients only, while this was not the case in healthy control [<i>F</i>(1109) = 8.92, <i>P</i> = 0.003, <i>d</i> = 0.541]. Moreover, patients with the AA-genotype (minor allele) of the rs53576 genetic variant of the <i>OXTR</i> gene presented with higher <i>OXTR</i> methylation levels [<i>F</i>(2106) = 10.25, <i>P <</i> 0.0001, <i>d</i> = 0.58]. Lastly, amygdalar connectivity to the hippocampus, the posterior cingulate cortex, the inferior parietal cortex and the inferior temporal cortex as well as smaller amygdalar volume were correlated to peripheral oxytocin levels in patients only [<i>F</i>(2,38) = 5.36, <i>P</i> = 0.025, <i>d</i> = 0.431], but not in healthy control. No significant interactions with childhood trauma were identified. Our study revealed a significant interplay between peripheral oxytocin and <i>OXTR</i> methylation in patients only, potentially influenced by genotype. One could hypothesize that higher peripheral oxytocin denotes a compensatory mechanisms for the increased methylation of the <i>OXTR</i>, which might affect amygdalar functional connectivity. These findings help to further understand underlying pathophysiological mechanisms, considering oxytocin's involvement in functional patients and could offer a potential site of treatment for future studies.</p>","PeriodicalId":93915,"journal":{"name":"Brain communications","volume":"7 1","pages":"fcae455"},"PeriodicalIF":4.1000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11670354/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/braincomms/fcae455","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Individuals diagnosed with functional neurological disorder experience abnormal movement, gait, sensory processing or functional seizures, for which research into the pathophysiology identified psychosocial contributing factors as well as promising biomarkers. Recent pilot studies suggested that (epi-)genetic variants may act as vulnerability factors, for example, on the oxytocin pathway. This study set out to explore endogenous oxytocin hormone levels in saliva in a cohort of 59 functional neurological disorder patients and 65 healthy controls comparable in sex and age. First, we examined the association between salivary oxytocin levels with the genetic allelic variant (rs53576) of the oxytocin receptor gene (OXTR), its epigenetic changes indicated by methylation rates, and clinical variables-including childhood trauma. Second, due to previously reported effects of oxytocin changing the volume and functional connectivity of the amygdala, as well as the known involvement of the amygdala in the pathophysiology of functional neurological disorders, we further looked at both structural and functional imaging of the amygdala. While patients did not significantly differ from healthy control in their peripheral oxytocin levels, there was a specific interaction of OXTR methylation and peripheral oxytocin dependent on group: higher methylation rates correlated with higher salivary oxytocin in patients only, while this was not the case in healthy control [F(1109) = 8.92, P = 0.003, d = 0.541]. Moreover, patients with the AA-genotype (minor allele) of the rs53576 genetic variant of the OXTR gene presented with higher OXTR methylation levels [F(2106) = 10.25, P < 0.0001, d = 0.58]. Lastly, amygdalar connectivity to the hippocampus, the posterior cingulate cortex, the inferior parietal cortex and the inferior temporal cortex as well as smaller amygdalar volume were correlated to peripheral oxytocin levels in patients only [F(2,38) = 5.36, P = 0.025, d = 0.431], but not in healthy control. No significant interactions with childhood trauma were identified. Our study revealed a significant interplay between peripheral oxytocin and OXTR methylation in patients only, potentially influenced by genotype. One could hypothesize that higher peripheral oxytocin denotes a compensatory mechanisms for the increased methylation of the OXTR, which might affect amygdalar functional connectivity. These findings help to further understand underlying pathophysiological mechanisms, considering oxytocin's involvement in functional patients and could offer a potential site of treatment for future studies.
被诊断为功能性神经障碍的个体会经历异常的运动、步态、感觉处理或功能性癫痫发作,病理生理学研究确定了社会心理因素以及有希望的生物标志物。最近的初步研究表明,(epi-)基因变异可能作为易感因素,例如,在催产素途径上。本研究旨在探讨59名功能性神经障碍患者和65名性别和年龄相当的健康对照者唾液中的内源性催产素水平。首先,我们研究了唾液催产素水平与催产素受体基因(OXTR)的等位基因变异(rs53576)、甲基化率显示的表观遗传变化以及包括童年创伤在内的临床变量之间的关系。其次,由于先前报道的催产素改变杏仁核的体积和功能连接的影响,以及已知的杏仁核参与功能性神经疾病的病理生理学,我们进一步研究了杏仁核的结构和功能成像。虽然患者的外周催产素水平与健康对照组没有显著差异,但OXTR甲基化与外周催产素之间存在特定的相互作用:只有患者的甲基化率较高,唾液催产素水平较高,而健康对照组并非如此[F(1109) = 8.92, P = 0.003, d = 0.541]。此外,携带OXTR基因rs53576遗传变异aa基因型(次要等位基因)的患者OXTR甲基化水平较高[F(2106) = 10.25, P 0.0001, d = 0.58]。最后,杏仁核与海马、后扣带皮层、下顶叶皮层和下颞叶皮层的连通性以及较小的杏仁核体积仅在患者中与外周催产素水平相关[F(2,38) = 5.36, P = 0.025, d = 0.431],而在健康对照组中则无关。未发现与儿童创伤有显著的相互作用。我们的研究揭示了外周催产素和OXTR甲基化之间的显著相互作用,仅在患者中,可能受到基因型的影响。人们可以假设,外周催产素水平的升高表明了OXTR甲基化增加的补偿机制,这可能会影响杏仁核的功能连接。这些发现有助于进一步了解潜在的病理生理机制,考虑到催产素在功能性患者中的作用,并可能为未来的研究提供潜在的治疗场所。